
Draco Lifesciences Private Limited
About Draco Lifesciences Private Limited
Data last updated:
Draco Lifesciences Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Unicorn Pharmachem Private Limited. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 21 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2011PTC222207. Its GSTIN is 27AAECD0330M1ZT (Maharashtra).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹2.03 Lakh. It is led by directors including Vijay Indravadan Dave and Bhavesh Vallabhdas Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.47 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹1.21 Lakh (net margin 3.2%) and EBITDA of ₹10.44 Lakh (EBITDA margin 27.9%). Revenue has grown at a compounded annual rate (CAGR) of 257% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Draco Lifesciences Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address403 Shreeji Arcade Junction Of S.V. Road & M.G. Road Kandi, Vali West, Mumbai, Maharashtra, India – 400067
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Draco Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Draco Lifesciences is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Draco Lifesciences Private Limited, buy the company report.
Financials of Draco Lifesciences Private Limited
FY 2024 filings availableDraco Lifesciences Private Limited reported revenue of ₹37.47 Lakh (up 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 39% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.9% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Draco Lifesciences Private Limited, buy the company report.
Board of directors of Draco Lifesciences Private Limited
Draco Lifesciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Indravadan Dave Also directs: Unicorn Pharmachem Private Limited | Director | 21 Sep 2011 | 15 Years 1 Months | Current |
| Bhavesh Vallabhdas Shah Also directs: Unicorn Pharmachem Private Limited | Director | 21 Sep 2011 | 15 Years 1 Months | Current |
| Kamal Surya Patcha | Director | 21 Sep 2011 | 15 Years 1 Months | Current |
Auditor
Draco Lifesciences Private Limited is audited by ASHOK PANDIT & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHOK PANDIT & CO | FY 2023 | 100674W |
Shareholding
The shareholding of Draco Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Draco Lifesciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Draco Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Draco Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Draco Lifesciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECD0330M1ZT | Maharashtra | Active | 23 Aug 2017 |
To see the full GST registrations and return filing status of Draco Lifesciences Private Limited, buy the company report.
Recent activity
Draco Lifesciences Private Limited has 4 board changes on record since 2011: 3 appointments and 1 cessation. The latest: Bhetalam Bapiraju ceased to be Additional Director on 30 Sep 2016.
Frequently asked questions
Draco Lifesciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 21 September 2011 (15+ years old) and is registered under CIN U24233MH2011PTC222207.
Draco Lifesciences has 3 current directors:
- Vijay Indravadan Dave - Director
- Bhavesh Vallabhdas Shah - Director
- Kamal Surya Patcha - Director
The latest financial statements of Draco Lifesciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Draco Lifesciences is 27AAECD0330M1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Draco Lifesciences is U24233MH2011PTC222207. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Draco Lifesciences was incorporated on 21 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Bhetalam Bapiraju ceased to be Additional Director on 30 Sep 2016. Bhavesh Vallabhdas Shah was appointed as Director on 21 Sep 2011. Kamal Surya Patcha was appointed as Director on 21 Sep 2011. Draco Lifesciences has 4 board changes on record in total.
The registered office of Draco Lifesciences is at 403 Shreeji Arcade Junction Of S.V. Road & M.G. Road Kandi, Vali West, Mumbai, Maharashtra, India – 400067.
Draco Lifesciences operates in the chemicals and materials industry, in the chemical distribution and retail segment.
The compliance status of Draco Lifesciences is compliant as of 24 September 2026. The company is actively filing with the Registrar of Companies.

